Single-dose CAR-T therapy potentially curative in multiple myeloma - Medical Xpress
11.06.2025 07:32
A multi-institutional study led by the Icahn School of Medicine at Mount Sinai reports one-third of patients with relapsed or refractory multiple myeloma remained in remission for at least five years… [+3489 chars]